Clinical Report: Intravenous Oxycodone Hydrochloride Pharmacokinetics in Perioperative Patients Diagnosed with Liver Cancer

Overview

This study investigates the pharmacokinetics of intravenous oxycodone in perioperative liver cancer patients with normal liver function. Key findings indicate altered pharmacokinetic parameters, including reduced clearance and prolonged half-life, compared to healthy volunteers.

Background

Effective pain management in liver cancer patients is critical due to the high incidence of pain associated with the disease. Oxycodone is commonly used for postoperative analgesia, but its pharmacokinetics can be significantly altered in patients with liver cancer, necessitating a better understanding of its behavior in this population. This study aims to provide insights into the pharmacokinetics of oxycodone in perioperative liver cancer patients to inform individualized analgesic strategies.

Data Highlights

Key Findings

• Oxycodone clearance is reduced in perioperative liver cancer patients.
• The half-life of oxycodone is prolonged in this patient population.
• There is an increased volume of distribution for oxycodone in liver cancer patients.
• Elevated exposure (AUC) of oxycodone was observed compared to healthy volunteers.
• Significant sex-related differences were noted in the pharmacokinetics of oxycodone and noroxycodone.

Clinical Implications

The altered pharmacokinetics of oxycodone in perioperative liver cancer patients suggest a need for dose adjustments and careful monitoring. Individualized analgesic strategies may enhance pain management and minimize adverse effects in this population.

Conclusion

This study highlights the significant differences in oxycodone pharmacokinetics in perioperative liver cancer patients, emphasizing the importance of tailored analgesic approaches in this clinical setting.

Related Resources & Content

1. Gelli et al., Journal of Clinical Oncology, 2026 -- Adjuvant Hepatic Arterial Infusion After Surgery for Colorectal Liver Metastases
2. Comparative Study of Intrathecal Versus Intravenous Morphine for Postoperative Pain Management Following Hepatectomy: A Randomized Controlled Trial
3. CYP2D6 Testing and Postoperative Opioids, Conexiant
4. Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022 - PMC
5. Journal of Gastrointestinal Surgery — Fresh Frozen Plasma Transfusion During Surgery as a Predictor of Postoperative Morbidity After Partial Hepatectomy for Hepatocellular Carcinoma
6. Influence of aging on opioid dosing for perioperative pain management: a focus on pharmacokinetics - PMC
7. Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022 - PMC